These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20374351)

  • 1. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C; Vij AS
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A; Allison J; Hill J; Rothermel T; Saag K
    J Rheumatol; 2001 Jun; 28(6):1298-305. PubMed ID: 11409123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR; Westfall AO; Allison J; Becker A; Melton ME; Freeman A; Kiefe CI; MacArthur M; Ockershausen T; Stewart E; Weissman N; Saag KG
    Arch Intern Med; 2007 Mar; 167(6):591-6. PubMed ID: 17389291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care.
    Nielsen BR; Jørgensen NR; Schwarz P
    J Asthma; 2008 Aug; 45(6):519-22. PubMed ID: 18612907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
    Tanvetyanon T
    Cancer; 2005 Jan; 103(2):237-41. PubMed ID: 15597384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
    Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
    Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; Peñuela-Epalza M
    J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey to assess investigation and management protocols followed in dealing with steroid-induced osteoporosis.
    Peshin R; Phelan M
    Clin Rheumatol; 2007 Sep; 26(9):1439-43. PubMed ID: 17235655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
    Naunton M; Peterson GM; Jones G; Griffin GM; Bleasel MD
    J Rheumatol; 2004 Mar; 31(3):550-6. PubMed ID: 14994404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics.
    Solomon DH; Brookhart MA; Gandhi TK; Karson A; Gharib S; Orav EJ; Shaykevich S; Licari A; Cabral D; Bates DW
    Am J Med; 2004 Dec; 117(12):919-24. PubMed ID: 15629730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.